Answers are grounded in this paper and cite their sources.
This review highlights dyspnea's prevalence in critically ill patients and its connection to anxiety, suggesting targeted management strategies.
Critical care psychiatrists frequently manage anxiety and agitation in patients with respiratory distress, often related to underlying dyspnea, which is the subjective experience of breathing discomfort. Despite its high prevalence (30% to 50% in mechanically ventilated patients) and association with adverse outcomes including weaning failure and posttraumatic stress disorder, dyspnea remains underrecognized and undertreated in intensive care units (ICUs). This review details the pathophysiology of dyspnea, explores the neurobiological link between dyspnea and anxiety through shared neural circuits, and discusses associated clinical outcomes. Assessment uses self-report, including scoring severity of dyspnea when feasible, and observational tools, such as the Respiratory Distress Observation Scale (RDOS) and its variants (IC-RDOS, MV-RDOS) in noncommunicative patients. Effective management involves a multidisciplinary approach targeting underlying etiologies alongside symptom-based interventions (nonpharmacological and pharmacological, distinguishing opioid efficacy for dyspnea and anxiolytics for dyspnea-associated anxiety). Critical care psychiatrists can significantly contribute to management of patients in ICUs by identifying dyspnea and collaborating on comprehensive care plans.
No takes yet. Share an insight, caveat, or question.
Sole et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: